Cite
HARVARD Citation
Connolly, S. et al. (2017). Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet. 391 (10117), pp. 205-218. [Online].